Literature DB >> 33964730

Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge.

Payel J Roy1, Ryan Price2, Sugy Choi3, Zoe M Weinstein2, Edward Bernstein4, Chinazo O Cunningham5, Alexander Y Walley2.   

Abstract

BACKGROUND: Inpatient addiction consult services (ACS) lower barriers to accessing medications for opioid use disorder (MOUD), however not every patient recommended for MOUD links to outpatient care. We hypothesized that fewer days between discharge date and outpatient appointment date was associated with improved linkage to buprenorphine treatment among patients evaluated by an ACS.
METHODS: We extracted appointment and demographic data from electronic medical records and conducted retrospective chart review of adults diagnosed with opioid use disorder (OUD) evaluated by an ACS in Boston, MA between July 2015 and August 2017. These patients were initiated on or recommended buprenorphine treatment on discharge and provided follow-up appointment at our hospital post-discharge. Multivariable logistic regression assessed whether arrival to the appointment post-discharge was associated with shorter wait-times (0-1 vs. 2+ days).
RESULTS: In total, 142 patients were included. Among patients who had wait-times of 0-1 day, 63 % arrived to their appointment compared to wait-times of 2 or more days (42 %). There were no significant differences between groups based on age, gender, distance of residence from the hospital, insurance status, co-occurring alcohol use disorder diagnosis, or discharge with buprenorphine prescription. After adjusting for covariates, patients with 0-1 day of wait-time had 2.6 times the odds of arriving to their appointment [95 % CI 1.3-5.5] compared to patients who had 2+ days of wait-time.
CONCLUSION: For hospitalized patients with OUD evaluated for initiating MOUD, same- and next-day appointments are associated with increased odds of linkage to outpatient MOUD care post-discharge compared to waiting two or more days.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Buprenorphine; Inpatient; Opioids

Mesh:

Substances:

Year:  2021        PMID: 33964730      PMCID: PMC8180499          DOI: 10.1016/j.drugalcdep.2021.108703

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.852


  21 in total

1.  Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service.

Authors:  Courtney D Nordeck; Christopher Welsh; Robert P Schwartz; Shannon Gwin Mitchell; Art Cohen; Kevin E O'Grady; Jan Gryczynski
Journal:  Drug Alcohol Depend       Date:  2018-03-02       Impact factor: 4.492

2.  Treatment utilization among persons with opioid use disorder in the United States.

Authors:  Li-Tzy Wu; He Zhu; Marvin S Swartz
Journal:  Drug Alcohol Depend       Date:  2016-10-19       Impact factor: 4.492

3.  Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.

Authors:  Marc R Larochelle; Dana Bernson; Thomas Land; Thomas J Stopka; Na Wang; Ziming Xuan; Sarah M Bagley; Jane M Liebschutz; Alexander Y Walley
Journal:  Ann Intern Med       Date:  2018-06-19       Impact factor: 25.391

4.  Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis.

Authors:  Alexander Y Walley; Michael Paasche-Orlow; Eugene C Lee; Shaula Forsythe; Veerappa K Chetty; Suzanne Mitchell; Brian W Jack
Journal:  J Addict Med       Date:  2012-03       Impact factor: 3.702

5.  Brief Report: Low-Barrier Buprenorphine Initiation Predicts Treatment Retention Among Latinx and Non-Latinx Primary Care Patients.

Authors:  Christina S Lee; Robert Rosales; Michael D Stein; Mariana Nicholls; Bridget M O'Connor; Vanessa Loukas Ryan; Elizabeth A Davis
Journal:  Am J Addict       Date:  2019-06-28

6.  Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.

Authors:  Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2019-12       Impact factor: 5.128

7.  Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.

Authors:  Torkel Richert; Björn Johnson
Journal:  Harm Reduct J       Date:  2015-02-18

8.  Lead time for appointment and the no-show rate in an ophthalmology clinic.

Authors:  Michael J McMullen; Peter A Netland
Journal:  Clin Ophthalmol       Date:  2015-03-18

9.  Retention of patients in opioid substitution treatment: A systematic review.

Authors:  Aisling Máire O'Connor; Gráinne Cousins; Louise Durand; Joe Barry; Fiona Boland
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

10.  The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial.

Authors:  Sarah E Wakeman; Nancy A Rigotti; Grace E Herman; Susan Regan; Yuchiao Chang; Rachel Snow; Benjamin Isenberg; Joshua P Metlay
Journal:  Subst Abus       Date:  2020-09-03       Impact factor: 3.716

View more
  4 in total

1.  Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.

Authors:  James H Ford; Arveen Kaur; Deepika Rao; Aaron Gilson; Daniel M Bolt; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  Implement Res Pract       Date:  2021-09-17

2.  Peer providers and linkage with buprenorphine care after hospitalization: A retrospective cohort study.

Authors:  Helen E Jack; Eric D Denisiuk; Brett A Collins; Dan Stephens; Kendra L Blalock; Jared W Klein; Elenore P Bhatraju; Joseph O Merrill; Kevin A Hallgren; Judith I Tsui
Journal:  Subst Abus       Date:  2022-12       Impact factor: 3.984

3.  Wait No Longer: Reducing Medication Wait-Times for Individuals with Co-Occurring Disorders.

Authors:  James H Ford; Deepika Rao; Aaron Gilson; Arveen Kaur; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  J Dual Diagn       Date:  2022-04-07

Review 4.  A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews.

Authors:  Honora Englander; Amy Jones; Noa Krawczyk; Alisa Patten; Timothy Roberts; P Todd Korthuis; Jennifer McNeely
Journal:  J Gen Intern Med       Date:  2022-05-09       Impact factor: 6.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.